| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |